Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue
Tumor tissues from biopsies or surgery are major sources for the next generation sequencing (NGS) study, but these procedures are invasive and have limitation to overcome intratumor heterogeneity. Recent studies have shown that driver alterations in tumor tissues can be detected by liquid biopsy whi...
Saved in:
Main Authors: | Jieun Lee, Sung-Min Cho, Min Sung Kim, Sug Hyung Lee, Yeun-Jun Chung, Seung-Hyun Jung |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2017-03-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | http://genominfo.org/upload/pdf/gni-15-48.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01) -
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE‐4.5 study
by: Susanne Klein‐Scory, et al.
Published: (2025-02-01) -
Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol
by: Magnús P.B. Obinah, et al.
Published: (2025-02-01) -
The role of circulating tumor DNA in melanomas of the uveal tract
by: Mohammed Zeeshan Zameer, et al.
Published: (2024-12-01) -
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
by: Joy A Awosika, et al.
Published: (2024-12-01)